EU To Announce Deal With Pfizer, Other Vaccine Makers To Reserve Capacity For Up To 325M Vaccines Annually For Future Health Emergency
Portfolio Pulse from Charles Gross
The European Union is set to announce a deal with Pfizer and other vaccine manufacturers to reserve capacity for up to 325 million vaccines annually for future health emergencies, according to Reuters.
June 30, 2023 | 9:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer is part of a deal with the EU to reserve capacity for future vaccine production. This could potentially increase Pfizer's revenues and stability.
The deal with the EU provides Pfizer with a guaranteed market for its vaccines, potentially increasing its revenues and providing stability in case of future health emergencies. This is likely to be viewed positively by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
The deal between the EU and vaccine manufacturers, including Pfizer, could potentially impact the VGK ETF, which includes European stocks.
The VGK ETF includes European stocks. The deal between the EU and vaccine manufacturers could potentially impact the ETF, depending on the specifics of the deal and the companies involved.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50